These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Differential activation of receptors and signal pathways upon stimulation by different doses of sphingosine-1-phosphate in endothelial cells. Li Q; Chen B; Zeng C; Fan A; Yuan Y; Guo X; Huang X; Huang Q Exp Physiol; 2015 Jan; 100(1):95-107. PubMed ID: 25557733 [TBL] [Abstract][Full Text] [Related]
14. Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis. Hemdan NY; Weigel C; Reimann CM; Gräler MH Eur J Immunol; 2016 Dec; 46(12):2767-2777. PubMed ID: 27683081 [TBL] [Abstract][Full Text] [Related]
15. Fingolimod does not prevent syndecan-4 shedding from the endothelial glycocalyx in a cultured human umbilical vein endothelial cell model of vascular injury. Milford EM; Meital L; Kuballa A; Reade MC; Russell FD Intensive Care Med Exp; 2022 Aug; 10(1):34. PubMed ID: 35980492 [TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain. Singh SK; Spiegel S Adv Biol Regul; 2020 Jan; 75():100670. PubMed ID: 31708456 [TBL] [Abstract][Full Text] [Related]
17. Synthetic analogs of FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] differentially regulate pulmonary vascular permeability in vivo and in vitro. Camp SM; Bittman R; Chiang ET; Moreno-Vinasco L; Mirzapoiazova T; Sammani S; Lu X; Sun C; Harbeck M; Roe M; Natarajan V; Garcia JG; Dudek SM J Pharmacol Exp Ther; 2009 Oct; 331(1):54-64. PubMed ID: 19592667 [TBL] [Abstract][Full Text] [Related]